Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | TEVA | BBIO | RDY | SUPN |
| Company | Cymabay Therapeutics | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 32.49 | 34.20 | 75.07 | 14.34 | 51.65 |
| High | 32.50 | 34.40 | 76.81 | 14.48 | 51.65 |
| Low | 32.48 | 33.57 | 73.84 | 14.27 | 50.03 |
| Latest | 32.48 | 34.11 | 73.93 | 14.42 | 50.20 |
| Change | +0.01 | -0.30 | -1.92 | +0.02 | -1.42 |
| % Change | +0.03% | -0.87% | -2.53% | +0.14% | -2.75% |
| Volume | 8,356,200 | 7,246,778 | 2,365,520 | 2,457,826 | 494,613 |
| 20-Day Average Volume | 3,390,805 | 10,634,804 | 3,097,611 | 2,126,071 | 701,811 |
| Previous Close | 32.47 | 34.41 | 75.85 | 14.40 | 51.62 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 33.78 | 75.40 | 13.87 | 49.76 |
| 20-Day Raw Stochastic | 94.12% | 49.49% | 50.18% | 96.51% | 61.91% |
| 20-Day Relative Strength | 78.00 | 60.96 | 49.34 | 60.29 | 51.62 |
| Weighted Alpha | +247.60 | +127.87 | +103.99 | +7.49 | +51.70 |
| Today's Opinion | 100% Buy | 100% Buy | 40% Buy | 8% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | 8% Sell | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | -0.76% since 02/10/26 | +2.01% since 02/10/26 | +2.71% since 02/10/26 | -1.91% since 02/10/26 |
| Low | 32.44 on 03/15/24 | 33.57 on 02/18/26 | 70.09 on 02/11/26 | 14.05 on 02/11/26 | 49.46 on 02/13/26 |
| High | 32.50 on 03/21/24 | 35.32 on 02/17/26 | 84.94 on 02/12/26 | 14.48 on 02/18/26 | 51.97 on 02/17/26 |
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | +7.40% since 01/16/26 | -3.06% since 01/16/26 | +11.61% since 01/16/26 | +0.40% since 01/16/26 |
| Low | 32.15 on 02/22/24 | 30.70 on 01/20/26 | 62.84 on 02/05/26 | 12.81 on 01/20/26 | 47.29 on 02/03/26 |
| High | 32.50 on 03/21/24 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | 14.48 on 02/18/26 | 51.99 on 02/06/26 |
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | +37.32% since 11/18/25 | +12.72% since 11/18/25 | +2.85% since 11/18/25 | +11.80% since 11/18/25 |
| Low | 22.11 on 01/26/24 | 24.01 on 11/21/25 | 62.84 on 02/05/26 | 12.81 on 01/20/26 | 44.09 on 12/02/25 |
| High | 32.50 on 03/21/24 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | 14.48 on 02/18/26 | 52.50 on 01/12/26 |
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | +88.87% since 08/18/25 | +50.82% since 08/18/25 | +1.34% since 08/18/25 | +16.77% since 08/18/25 |
| Low | 12.32 on 10/13/23 | 17.33 on 08/20/25 | 46.81 on 08/25/25 | 12.81 on 01/20/26 | 41.78 on 08/20/25 |
| High | 32.50 on 03/21/24 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | 15.06 on 09/17/25 | 57.65 on 10/30/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 39,565,064 | 14,616,976 | 12,023,106 | 2,959,839 |
| Shares Outstanding, K | 114,724 | 1,149,813 | 192,709 | 834,938 | 57,339 |
| Annual Sales | 31,070,000 | 17,258,000,000 | 221,900,000 | 3,811,000,000 | 661,820,000 |
| Annual Net Income | -105,370,000 | 1,411,000,000 | -535,760,000 | 663,000,000 | 73,870,000 |
| Last Quarter Sales | 60,000 | 4,711,000,000 | 120,700,000 | 977,400,000 | 192,100,000 |
| Last Quarter Net Income | -41,900,000 | 481,000,000 | -182,740,000 | 135,500,000 | -45,120,000 |
| 60-Month Beta | 0.32 | 0.70 | 1.13 | 0.35 | 0.71 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.96 on 01/28/26 | -0.95 on 10/29/25 | 0.19 on 10/24/25 | 1.01 on 11/04/25 |
| Latest Earnings Date | 05/20/24 | 05/06/26 | 02/19/26 | 05/08/26 | 02/24/26 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | N/A | 0.071 on 07/25/25 | N/A |
| Next Ex-Dividends Date | N/A | 11/27/17 | N/A | 07/25/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 12.09 | 0.00 | 18.36 | 23.87 |